Search
for
Sort by
Research 721–750 of 1000+
- The state‐of‐the‐art in the management of androgenetic alopecia: A review of new therapies and treatment algorithms
- Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA
- High-throughput screening of small molecule Wnt/β-catenin activators for hair and nail growth
- Is the Safety of Finasteride Correlated With Its Route of Administration: Topical Versus Oral? A Pharmacovigilance Study With Data From the United States Food and Drug Administration Adverse Event Reporting System
- An update on nanocarriers for follicular-targeted drug delivery for androgenetic alopecia topical treatment
- Hormonal Therapies for Acne: A Comprehensive Update for Dermatologists
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- High-Throughput Screening for Discovering Small Molecules Capable of Increasing the Wnt/β-Catenin Signaling Pathway to Promote Hair and Nail Growth
- 43696 Early real-world experience with baricitinib in the treatment of severe alopecia areata
- Comprehensive Study of Drug-Induced Pruritus Based on Adverse Drug Reaction Report Database
- Drug Repurposing against KRAS Mutant G12C: A Machine Learning, Molecular Docking, and Molecular Dynamics Study
- The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases
- An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature
- Pediatric Systemic Lupus Erythematosus
- Coming full circle (almost): Low dose oral minoxidil for alopecia
- Identification of the sulfotransferase iso-enzyme primarily responsible for the bio-activation of topical minoxidil.
- ODAC Chairs Reveal Challenges, High Drama in a Decade of Service
- Spectrum and signals of medication-associated cognitive disorder: a comprehensive disproportionality analysis with cross-database validation
- Novel drugs of United States Food and Drug Administration approved in 2024
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
- Notes from the Editor Emeritus
- Index of the human papillomavirus (HPV) vaccine industry clinical study programmes and non-industry funded studies: a necessary basis to address reporting bias in a systematic review
- Update on the pathogenesis, genetics and medical treatment of patterned hair loss.
- Androgens and acne: perspectives on clascoterone, the first topical androgen receptor antagonist
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Endocrine disorders and hormonal therapy for adolescent acne
- Biologics in the management of childhood atopic dermatitis
- The safety profiles of avacopan on microscopic polyangiitis and granulomatosis with polyangiitis: a real-world pharmacovigilance analysis
- Updates in Vitiligo
- Dutasteride for the Treatment of Androgenetic Alopecia: An Updated Review